BerGenBio Balance Sheet Health
Financial Health criteria checks 5/6
BerGenBio has a total shareholder equity of NOK153.4M and total debt of NOK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NOK194.7M and NOK41.4M respectively.
Key information
0%
Debt to equity ratio
NOK 0
Debt
| Interest coverage ratio | n/a |
| Cash | NOK 174.84m |
| Equity | NOK 153.38m |
| Total liabilities | NOK 41.36m |
| Total assets | NOK 194.74m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 7BG0's short term assets (NOK194.6M) exceed its short term liabilities (NOK41.4M).
Long Term Liabilities: 7BG0 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 7BG0 is debt free.
Reducing Debt: 7BG0 has no debt compared to 5 years ago when its debt to equity ratio was 0.02%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 7BG0 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 7BG0 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 3.6% each year